ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation, filed this Current Report on Form 8-K on November 8, 2024. The filing serves to announce the financial results for the third quarter ended September 30, 2024. The company's common stock trades on the NASDAQ Stock Market under the symbol ULBI.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that these results were issued via a press release (Exhibit 99.1) but does not embed the financial data within the 8-K text itself.
Material Changes
No material changes or comparative financial data are detailed in this specific filing text. The report references the attached press release for the full disclosure of results and any changes versus prior periods.
Guidance, Outlook, and Risks
This filing does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. Such information is contained within the referenced press release attached as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2024) for actual Q3 2024 revenue and earnings figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Check for any updated full-year guidance or operational outlook provided in the press release.
- Confirm the absence of unusual items or restatements in the detailed financial statements referenced by the filing.